DIRECT ACCESS

Discover the latest program

Explore plenary lectures, symposia, oral communications & round tables.

Discover →

Late Call for Abstract

Deadline: January 15, 2026

Submit your work →

Venue

Discover the conference venue and practical information for your stay in Washington, DC.

More info →

About the Intrinsic Capacity, Frailty and Sarcopenia Research Conference for Geroscience and Healthy Longevity

Over the past 13 years, the International Conference on Frailty and Sarcopenia Research (ICFSR) has evolved into a globally recognized platform for advancing clinical trials and translational science in older adults. The conference has brought together researchers, clinicians, and innovators to explore interventions that prevent frailty, preserve physical function, and delay dependency—through nutrition, exercise, geroscience-guided therapies, and other approaches.

Reflecting advances in the science of aging, the conference now embraces a broader, unifying vision as the Intrinsic Capacity, Frailty and Sarcopenia Research Conference for Healthy Longevity. This focus highlights the growing importance of Intrinsic Capacity (IC)—the composite of all physical and mental capacities of an individual—as a cornerstone of modern aging research. By complementing the concept of frailty, IC shifts the perspective from deficits toward preserving function, resilience, and quality of life. Recent high-impact studies have shown how IC can be measured and applied as a practical framework for both biological aging research and clinical intervention. Intrinsic Capacity is translated into clinical practice worldwide with the ICOPE program from the World Health Organization.

Looking Ahead to ICFSR 2026 – Washington, DC

The 2026 conference will be co-hosted by the Johns Hopkins Artificial Intelligence and Technology Collaboratory for Aging Research (AITC) and the Johns Hopkins Older Americans Independence Center (OAIC). Dr. Peter Abadir, Principal Investigator of the AITC and Associate Professor at Johns Hopkins, looks forward to welcoming the global research community. A leader in translational aging research, Dr. Abadir’s work bridges basic science and clinical innovation, with a focus on the molecular mechanisms of frailty, resilience, and age-related decline.

ICFSR 2026 will build on this success with a sharpened focus on:

• Intrinsic Capacity as a clinical and trial-ready framework
• Biomarkers of aging and frailty for personalized medicine
• Geroscience-based therapies to enhance resilience and delay dependency
• Artificial Intelligence for scalable prediction and prevention of age-related decline

At this pivotal moment in aging science, ICFSR continues to reflect the interdisciplinary vision that unites the global community: to intervene earlier, preserve independence, and extend healthy lifespan in older adults.

All abstracts submitted to the ICFSR conference are sent to the ICFSR Scientific Committee for a very selective and thorough peer-review before final acceptance. However, industry scientists are invited to present their work via the same abstract submission and peer-review process.

The ICFSR also promotes the publication of the Journal of Frailty and Aging (JFA) providing both online access and print copies to over 1,000 teams worldwide involved in the prevention of frailty and dependency in older adults.